Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if INTS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
2 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
17 filers reported a long position in INTS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | $2M | 496.5K | +1,204.7% |
| KMT WEALTH MANAGEMENT, LLC | $2M | 496.5K | New |
| Rothschild Wealth LLC | $109.6K | 26.7K | +14.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $108.9K | 26.6K | +57.8% |
| SAPIENT CAPITAL LLC | $106.6K | 26K | Unchanged |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $102.5K | 25K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $93.4K | 22.8K | -12.4% |
| FNY Investment Advisers, LLC | $90K | 22K | New |
| Mesirow Financial Investment Management, Inc. | $57.9K | 14.1K | Unchanged |
| VANGUARD FIDUCIARY TRUST CO | $37.4K | 9.1K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.